MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.

Autor: van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Louis FM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Kessels R; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mandjes IA; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Agterof MJ; Department of Medical Oncology, St Antonius Hospital, Nieuwegein, Netherlands., van der Steeg WA; Department of Medical Oncology, Isala, Zwolle, Netherlands., Heijns JB; Department of Medical Oncology, Amphia, Breda, Netherlands., van Bekkum ML; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands., Siemerink EJ; Department of Medical Oncology, Ziekenhuisgroep Twente, Hengelo, Netherlands., Kuijer PM; Department of Medical Oncology, Spaarne Gasthuis Hoofdorp, Netherlands., Scholten A; Department of Radiation, Netherlands Cancer Institute, Amsterdam, Netherlands., Wesseling J; Division of Molecular Pathology and Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Leiden, Netherlands., Vrancken Peeters MTFD; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, Netherlands., Mann RM; Department of Radiology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Imaging, Radboud University Medical Center, Amsterdam, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Amsterdam University Medical Centre, Amsterdam, Netherlands. Electronic address: g.sonke@nki.nl.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. 603-613. Date of Electronic Publication: 2024 Apr 05.

The clinical course of patients with suspected pulmonary embolism.

Autor: van Beek EJ, Kuijer PM, Büller HR, Brandjes DP, Bossuyt PM, ten Cate JW

Publikováno v: Archives of Internal Medicine; 12/08/97, Vol. 157 Issue 22, p2593-2598, 6p

Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

Autor: Kuijer PM; Center for Haemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, University of Amsterdam, The Netherlands. c.c.keyzers@amc.uva.nl, Hutten BA, Prins MH, Büller HR

Publikováno v: Archives of internal medicine [Arch Intern Med] 1999 Mar 08; Vol. 159 (5), pp. 457-60.

The role of a decision rule in symptomatic pulmonary embolism patients with a non-high probability ventilation-perfusion scan.

Autor: Michel BC; Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands., Kuijer PM, McDonnell J, van Beek EJ, Rutten FF, Büller HR

Publikováno v: Thrombosis and haemostasis [Thromb Haemost] 1997 Aug; Vol. 78 (2), pp. 794-8.

Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism.

Autor: Turkstra F; University of Amsterdam, The Netherlands., Kuijer PM, van Beek EJ, Brandjes DP, ten Cate JW, Büller HR

Publikováno v: Annals of internal medicine [Ann Intern Med] 1997 May 15; Vol. 126 (10), pp. 775-81.